Physician profile
Esther Ogunjimi
NPI 1013229871
$24,918.63
in general payments reported to CMS, 2019-2025
10 companies · $1,303 in 2025
The $1,303 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,791 · 2022: $8,549 · 2023: $7,095 · 2024: $179 · 2025: $1,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,080 · Travel and Lodging: $1,621 · Food and Beverage: $502 · Education: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,080.00 |
| Travel and Lodging | $1,620.77 |
| Food and Beverage | $502.22 |
| Education | $375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,358.57 | 2021-2025 | |
| Becton, Dickinson and Company | $11,945.47 | 2022-2023 | Bd Onclarity |
| Astellas Pharma US INC | $237.97 | 2022 | |
| Coopersurgical, INC. | $120.24 | 2023-2024 | Advincula Delineator Uterine Manipulator, Summit Doppler |
| Baxter Healthcare | $93.54 | 2023 | Adept |
| Bayer Healthcare Pharmaceuticals INC. | $52.20 | 2022 | |
| Daiichi Sankyo INC. | $45.38 | 2022-2024 | Injectafer |
| Applied Medical Resources Corporation | $25.53 | 2022 | |
| Organon LLC | $23.62 | 2025 | Jada System |
| Abbvie INC. | $16.11 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Ogunjimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.